
1. trop med int health. 2012 aug;17(8):989-1000. doi:
10.1111/j.1365-3156.2012.03016.x. epub 2012 may 30.

plasmodium vivax duffy binding protein: baseline antibody responses parasite 
polymorphisms well-consolidated settlement amazon region.

kano fs(1), sanchez ba, sousa tn, tang ml, saliba j, oliveira fm, nogueira pa,
gonçalves aq, fontes cj, soares is, brito cf, rocha rs, carvalho lh.

author information: 
(1)laboratório de malária, centro de pesquisas rené rachou/fiocruz, belo
horizonte-mg, brazil.

objective: investigate risk factors associated acquisition of
antibodies plasmodium vivax duffy binding protein (pvdbp) - leading
malaria vaccine candidate - well-consolidated agricultural settlement the
brazilian amazon region determine sequence diversity pvdbp
ligand domain (dbp(ii)) within local malaria parasite population.
methods: demographic, epidemiological clinical data collected 541
volunteers using structured questionnaire. malaria parasites detected by
conventional microscopy pcr, blood collection used antibody
assays molecular characterisation dbp(ii).
results: frequency malaria infection 7% (6% p. vivax 1% p.
falciparum), malaria cases clustered near mosquito breeding sites. nearly
50% settlers anti-pvdbp igg antibodies, detected enzyme-linked
immunosorbent assay (elisa) subject's age strong predictor of
seropositivity pvdbp. unexpectedly, low levels dbp(ii) diversity found
within local malaria parasites, suggesting existence low gene flow
between p. vivax populations, probably due relative isolation the
studied settlement.
conclusion: recognition pvdbp significant proportion the
community, associated low levels dbp(ii) diversity among local p. vivax, 
reinforces variety malaria transmission patterns communities from
frontier settlements. studies provide baseline information for
antimalarial vaccines development.

© 2012 blackwell publishing ltd.

doi: 10.1111/j.1365-3156.2012.03016.x 
pmid: 22643072  [indexed medline]

